• One-stop Service

    One-stop service includes cell pool screening, high yield cell selection, cell amplification, stability prediction, and delivery of cell banks and relevant files. 

  • Customer Cloud Service

    The customer cloud service remotely provides customers with real-time image scanning and image analysis, can locate the target cells in a short time.

    COOPERATION METHOD

  • Pay after Service

    Qualified customers can pay after service without any risks.

Developed by Great Bay Bio, Klone4.0 is a biotechnological service platform focusing on cell line development. It can screen hundreds of thousands of cells at one time, obtain cell images, and quickly analyze and locate high-yield cells through AI technology and unique cell selecting technology. It can obtain high-yield and high-quality single cells in 4 hours. 

Platform Introduction

降低80%的开发时间

开发时间约1.5~2个月

快速

高量

更多的候选细胞株

 

是传统的3~5倍

高产率

比传统方式高数倍

短期内获取高表达量单细胞

预测稳定性

行业首创

提前预测细胞稳定性

平台价值

4 小时单克隆化

Much higher Qp than the traditional way

 

Obtain high yield single cells in a short time

High Yield

Save up to 80 % workload

 

Develop cell lines in 1.5~2 months

Fast

Monoclone cells selection in 4 hours

Platform value

More

More cell line candidates

Stability Prediction

Original technology

 

Predict the cell line stability in 15 days

Clonality in 4 hours


Making cell line development easier and more efficient

Process Flow

MORE

Platform Introduction

Klone4.0 is a cell line development platform of Great Bay Bio, which enables intelligent application of cell line construction through AI and precise cell selection technology.

One-stop Service

Customers experience the full value of the platform

Business Model

MORE

·  High yield cell lines

·  More cell line candidates

·  Cell line stability prediction

Platform Values

MORE

F A Q

MORE

Great Bay Bio attaches great importance to the frequently asked questions by clients

Q. How long does it take for Klone4.0 to develop the monoclonal cell line?

 

A:If customers provide cell pool, it takes1.5 months;

      If customers provide sequence, 2.5 months is needed.

 

 

 

Q. Is the monoclonal yield of Klone4.0 higher than that of traditional methods?

 

A:Compared with traditional methods, Klone4.0 can screen far more cells. Therefore, usually K4 can abtain higher yield cells if it stars with the same cell pool.

 

 

 


Q. Will the cells displace during the high-throughput photographing?

 
A:It has been proved that the cell positions can remain traceable, which can meet the experiment requirements.

 

 

 

Q. Will selecting technologies damage the cells?

 

A:Experiments have showed that the technologies won’t damage any cells and the monoclonal formation rate is equivalent to that of traditional technologies.

 

 

 

Q. How to determine monoclonality?

 

A:Klone4.0 platform uses high-throughput photographing technologies to verify the monoclonality.

 

 

 

Q. Does Klone 4.0 have independent intellectual property rights?

 

A:The key technologies involved are all independently developed by GBB. We have a sound intellectual property matrix and IP layouts at domestic and overseas.

 

 

 

Q. How to authorize the vector cell line?

 

A:Cell lines provided by customers needn’t be authorized any more. If customers prefer to use the contracted cell lines of Klone4.0, the license fee shall be calculated separately.

Frequently Asked Questions